EMERALD MUTUAL FUND ADVISERS TRUST - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 152 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2024$12,967,843
+52.8%
824,402
+56.6%
0.68%
+50.3%
Q4 2023$8,488,751
-40.7%
526,271
+64.9%
0.45%
-5.5%
Q1 2021$14,313,000
-21.4%
319,2020.0%0.48%
-25.1%
Q4 2020$18,217,000
+43.3%
319,202
+28.8%
0.63%
+12.6%
Q3 2020$12,709,000
+11.7%
247,748
+30.1%
0.56%
+4.8%
Q2 2020$11,376,000
+183.6%
190,482
+95.5%
0.54%
+113.9%
Q1 2020$4,011,000
-51.2%
97,432
-73.2%
0.25%
-23.0%
Q2 2019$8,211,000
-2.8%
364,1050.0%0.33%
-3.8%
Q1 2019$8,451,000
-34.4%
364,105
-40.6%
0.34%
-43.7%
Q4 2018$12,873,000
-50.2%
613,281
-8.1%
0.60%
-31.0%
Q3 2018$25,836,000
+28.2%
667,262
+30.3%
0.87%
+19.6%
Q2 2018$20,154,000
+132.2%
512,180
+18.3%
0.73%
+114.7%
Q1 2018$8,679,000
-8.0%
433,060
+4.0%
0.34%
-9.3%
Q4 2017$9,438,000
+70.1%
416,342
+42.5%
0.38%
+62.3%
Q3 2017$5,548,000292,1470.23%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$19,824,86914.35%
Redmile Group, LLC 3,593,317$58,894,4662.41%
BRAIDWELL LP 3,271,513$53,620,0981.80%
Parkman Healthcare Partners LLC 344,920$5,653,2391.50%
ARMISTICE CAPITAL, LLC 5,172,000$84,769,0801.48%
Ikarian Capital, LLC 367,119$6,017,0811.45%
Sunesis Advisors, LLC 96,299$1,578,3411.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,228$38,503,8470.80%
Hillsdale Investment Management Inc. 328,200$5,379,1980.46%
Avidity Partners Management LP 1,126,000$18,455,1400.40%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders